– SWITZERLAND, Basel – Novartis (SWX: NOVN) today announced that its Board of Directors has appointed Gilbert Ghostine as Chairman-designate of the new Board of Directors of Sandoz, which will be formed following the spin-off from Novartis in the second half of 2023, subject to final approvals.
About Gilbert Ghostine
Gilbert Ghostine has served as CEO of Geneva-based Firmenich, the world’s largest privately owned perfume and taste company, since 2014. He is an experienced business leader with a track record of growing and transforming businesses in competitive industries. He held executive and senior leadership positions at Firmenich and Diageo in a career spanning three decades.
Gilbert Ghostine currently serves on two boards of directors; at Danone, where he is a member of the audit committee, and at Four Seasons Hotels & Resorts, where he chairs the remuneration and nomination committee.
Gilbert Ghostine holds a master’s degree in Business Administration from Saint Joseph University, Lebanon,, and completed Harvard Business School’s Advanced Management Program.
About Sandoz
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company. Our broad portfolio of high-quality medicines, covering major therapeutic areas, accounted for 2022 sales of USD 9.2 billion.
For more, visit https://www.Sandoz.com
About Novartis
Novartis is reimagining medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 106,000 people of more than 140 nationalities work together to bring Novartis products to nearly 800 million people around the world.
For more, visit https://www.novartis.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
